Sex differences and cardiovascular risk.
作者信息
Cordero A, Alegria E
出版信息
Heart. 2006 Feb;92(2):145-6. doi: 10.1136/hrt.2005.069187.
Abstract
Cardiovascular risk factors such as diabetes confer differing degrees of risk in men and women.
摘要
相似文献
1
Sex differences and cardiovascular risk.
Heart. 2006 Feb;92(2):145-6. doi: 10.1136/hrt.2005.069187.
2
Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study.
Diabetes Care. 2008 Jan;31(1):69-74. doi: 10.2337/dc07-1244. Epub 2007 Oct 12.
3
[Is cardiovascular risk different in the diabetic woman?].
Diabetes Metab. 2001 Sep;27(4 Pt 2):S76-82.
4
Cardiovascular risk in women with diabetes.
Nutr Metab Cardiovasc Dis. 2010 Jul;20(6):474-80. doi: 10.1016/j.numecd.2010.01.008.
5
Dysglycaemia, cardiovascular outcome and treatment. Is the jury still out?
Eur Heart J. 2009 Jun;30(11):1301-4. doi: 10.1093/eurheartj/ehp168. Epub 2009 Apr 24.
6
Preventing cardiovascular diseases in people with diabetes.
Can J Cardiol. 1999 Dec;15 Suppl G:65G-8G.
7
8
Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.
Postgrad Med J. 2005 Jan;81(951):1-6. doi: 10.1136/pgmj.2004.020511.
9
Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors.
J Diabetes Complications. 2004 Nov-Dec;18(6):317-21. doi: 10.1016/S1056-8727(03)00072-2.
10
The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: point.
Int J Clin Pract Suppl. 2001 Sep(123):24-6.
引用本文的文献
1
Parasympathetic decreases immediately following self-reported cannabis smoking among adults living with cannabis use disorder.
Int J Psychophysiol. 2025 Aug;214:113211. doi: 10.1016/j.ijpsycho.2025.113211. Epub 2025 Jul 6.
2
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries.
BMC Med. 2024 Dec 2;22(1):567. doi: 10.1186/s12916-024-03792-3.
3
[Research on the cardiovascular function evaluation system based on noninvasive detection indices].
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2019 Aug 25;36(4):649-656. doi: 10.7507/1001-5515.201807064.
4
Control of cardiovascular risk factors and its determinants in the general population- findings from the STAAB cohort study.
BMC Cardiovasc Disord. 2017 Nov 2;17(1):276. doi: 10.1186/s12872-017-0708-x.
5
Meta-analysis: retinal vessel caliber and risk for coronary heart disease.
Ann Intern Med. 2009 Sep 15;151(6):404-13. doi: 10.7326/0003-4819-151-6-200909150-00005.
6
Retinal vascular calibre and the risk of coronary heart disease-related death.
Heart. 2006 Nov;92(11):1583-7. doi: 10.1136/hrt.2006.090522. Epub 2006 Jul 13.
本文引用的文献
1
Fasting hypertriglyceridaemia increases carotid intima-media thickness and impairs coronary microvascular functions in non-obese middle aged women but not in men.
Heart. 2006 Feb;92(2):259-60. doi: 10.1136/hrt.2005.064741.
2
Increasing trends of acute myocardial infarction in Spain: the MONICA-Catalonia Study.
Eur Heart J. 2005 Mar;26(5):505-15. doi: 10.1093/eurheartj/ehi068. Epub 2004 Dec 15.
3
New aspects in the pathogenesis of diabetic atherothrombosis.
J Am Coll Cardiol. 2004 Dec 21;44(12):2293-300. doi: 10.1016/j.jacc.2004.07.060.
4
Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study).
Am J Cardiol. 2004 Nov 15;94(10):1249-54. doi: 10.1016/j.amjcard.2004.07.107.
5
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
Lancet. 2004;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9.
6
C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
Circulation. 2004 Jul 27;110(4):380-5. doi: 10.1161/01.CIR.0000136581.59584.0E. Epub 2004 Jul 19.
7
Use of metabolic markers to identify overweight individuals who are insulin resistant.
Ann Intern Med. 2003 Nov 18;139(10):802-9. doi: 10.7326/0003-4819-139-10-200311180-00007.
8
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
Circulation. 2003 Jul 29;108(4):414-9. doi: 10.1161/01.CIR.0000080897.52664.94. Epub 2003 Jul 14.
9
NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.
Diabetes. 2003 May;52(5):1210-4. doi: 10.2337/diabetes.52.5.1210.
10
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
N Engl J Med. 2002 Nov 14;347(20):1557-65. doi: 10.1056/NEJMoa021993.
Zotero 插件